Company Data
Sangamo Therapeutics Inc.
Ticker
SGMO
Current Price
$1.33 45.67%
Market Cap
$276.9M
Price Target
Refer to Report
Volume
41.9M
52wk Range
$0.2911 - $1.48
Overview
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients’ lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company’s product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.